long-acting subcutaneous depot of octreotide under development for the treatment of three chronic and severe disease indications: acromegaly, gastroenteropancreatic neuroendocrine tumors (GEP-NET ...

Lantheus has filed what it says is the first generic version of Novartis’ big-selling cancer radionuclide therapy Lutathera in the US, used to treat rare neuroendocrine tumours (NETs).

Somatostatin analogs (e.g., octreotide, lanreotide) will continue to be main therapies for functioning neuroendocrine tumors over the next years. Pasireotide, a new panreceptor analog, might ...

This represents the first FDA approval of an oral therapy for PPGL, rare neuroendocrine tumors that can spread to other parts of the body. Welireg received approval from the FDA and European ...

Writer Jenny Lawson, also known as the Bloggess, has revealed that she’s been diagnosed with neuroendocrine cancer. She shared the news on her Instagram page and blog, making lighthearted jokes ...

“Pituitary tumors are the second most common manifestation. Although pancreatic neuroendocrine tumors are less prevalent, they are associated with a higher mortality risk in MEN1 patient ...

Carcinoid tumor of ... After 2 months of octreotide treatment, his diarrhea improved but flushing and particularly abdominal pain persisted. After a review by the neuroendocrine multidisciplinary ...

PPGLs are rare and related neuroendocrine tumors that can secrete catecholamines. Pheochromocytoma develops in the adrenal glands, while paraganglioma can develop in various other places.